Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATYR
2026
aTyr Pharma
ATYR
$54.8M
| $2.08M | ﹤0.01% |
574,455
-574,720
| -50% | -$1.74M |
|
2027
USCB Financial Holdings
USCB
$415M
| $2.08M | ﹤0.01% |
117,088
+17,488
| +18% | +$305K |
|
2028
Benchmark Electronics
BHE
$2.94B
| $2.08M | ﹤0.01% |
45,750
+2,050
| +5% | +$95.1K |
|
2029
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $2.08M | ﹤0.01% |
+43,100
| New | +$2.15M |
|
2030
Lloyds Banking Group
LYG
$90.1B
| $2.07M | ﹤0.01% |
762,340
+309,840
| +68% | +$885K |
|
2031
iShares Russell Top 200 ETF
IWL
$2.29B
| $2.07M | ﹤0.01% |
14,300
-1,700
| -11% | -$246K |
|
|
EDR
2032
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $2.07M | ﹤0.01% |
66,100
-975,028
| -94% | -$29M |
|
2033
ACV Auctions
ACVA
$1.4B
| $2.07M | ﹤0.01% |
95,700
-262,500
| -73% | -$5.31M |
|
2034
Xtrackers S&P 500 ESG ETF
SNPE
$2.79B
| $2.07M | ﹤0.01% |
38,800
+19,000
| +96% | +$1.02M |
|
|
NLOP
2035
Net Lease Office Properties
NLOP
$172M
| $2.07M | ﹤0.01% |
66,200
+28,800
| +77% | +$895K |
|
2036
Chemung Financial Corp
CHMG
$405M
| $2.07M | ﹤0.01% |
42,322
+3,581
| +9% | +$179K |
|
|
PRO
2037
DELISTED
PROS Holdings
PRO
| $2.06M | ﹤0.01% |
93,900
-13,000
| -12% | -$280K |
|
2038
Miller Industries
MLR
$645M
| $2.05M | ﹤0.01% |
31,400
-8,400
| -21% | -$572K |
|
|
OMCC
2039
DELISTED
Old Market Capital Corp
OMCC
| $2.05M | ﹤0.01% |
319,551
-14,600
| -4% | -$87.8K |
|
|
VERV
2040
DELISTED
Verve Therapeutics
VERV
| $2.05M | ﹤0.01% |
363,400
-211,386
| -37% | -$1.19M |
|
|
CHCT
2041
Community Healthcare Trust
CHCT
$432M
| $2.04M | ﹤0.01% |
106,400
-117,510
| -52% | -$2.13M |
|
2042
Garrett Motion
GTX
$5.41B
| $2.04M | ﹤0.01% |
226,286
-132,514
| -37% | -$1.1M |
|
2043
iShares MSCI Europe Financials ETF
EUFN
$4.31B
| $2.04M | ﹤0.01% |
87,600
-1,400
| -2% | -$33.5K |
|
|
FIRY
2044
Firy Inc
FIRY
$148M
| $2.04M | ﹤0.01% |
404,825
+6,200
| +2% | +$33.1K |
|
2045
First Trust Smith Unconstrained Bond ETF
UCON
$3.28B
| $2.02M | ﹤0.01% |
82,061
-280,010
| -77% | -$6.94M |
|
2046
Alerus Financial
ALRS
$838M
| $2.02M | ﹤0.01% |
+104,879
| New | +$2.3M |
|
2047
Taylor Devices
TAYD
$178M
| $2.02M | ﹤0.01% |
48,462
+2,400
| +5% | +$109K |
|
|
JAMF
2048
DELISTED
Jamf
JAMF
| $2.01M | ﹤0.01% |
143,400
+50,000
| +54% | +$788K |
|
2049
Blue Ridge Bankshares
BRBS
$331M
| $2.01M | ﹤0.01% |
625,200
+430,700
| +221% | +$1.36M |
|
2050
Parke Bancorp
PKBK
$413M
| $2.01M | ﹤0.01% |
98,134
-1,813
| -2% | -$39.6K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.